Kolexia
Geyl Sophie
Gastro-entérologie
Centre Hospitalier de Brive
Brive-la-Gaillarde, France
86 Activités
40 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Maladie de Crohn Adénomes Gastroparésie Syndrome de Gougerot-Sjögren Tumeurs du côlon Carcinomes Polypes coliques Constipation

Industries

Abbvie
12 collaboration(s)
Dernière en 2023
Ipsen
8 collaboration(s)
Dernière en 2021
Janssen
7 collaboration(s)
Dernière en 2023
Galapagos SASU
4 collaboration(s)
Dernière en 2023

Dernières activités

Endoscopic submucosal dissection of recurrent duodenal adenoma: combined use of multiple strategies for a difficult case.
Endoscopy   07 février 2024
TRENCH 1: TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study
Essai Clinique (Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives)   15 janvier 2024
Endoscopic intermuscular dissection of a residual rectal neuroendocrine tumor with high-pressure injection and double-clip traction.
Endoscopy   07 novembre 2023
Risk factors for stent dysfunction during long-term follow-up after EUS-guided biliary drainage using lumen-apposing metal stents: A prospective study.
Endoscopic ultrasound   31 octobre 2023
Risk of delayed bleeding after colorectal endoscopic submucosal dissection: the Limoges bleeding score.
Endoscopy   10 octobre 2023
Should colorectal endoscopic submucosal dissection defects be closed just because we can?
Endoscopy   27 septembre 2023
Cicatrisation transmurale dans la maladie de Crohn
Edimark   31 août 2023
Multitraction with a single rubber band and clips: a simple tip for endoscopic submucosal dissection of a recurrent lesion with previous clip.
Endoscopy   15 juin 2023
P638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn’s disease: a GETAID multicentre cohort study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study.
Alimentary pharmacology & therapeutics   19 décembre 2022